Biodesix Inc. (BDSX) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Join SI Premium – FREE
Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $8.83 million.
GUIDANCE:
Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of $38.4 million.
For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Choice Hotels (CHH) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
- Lightbridge (LTBR) Misses Q3 EPS by 23c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
